Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
World
Nimo Omer

Friday briefing: Are appetite-suppressing drugs really a fast track to weight loss?

A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk.
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk. Photograph: George Frey/Reuters

Good morning.

In the last year, a little known drug originally prescribed to people with type 2 diabetes has shot into the headlines. Semaglutide, sold by Novo Nordisk as Ozempic, has taken social media and Hollywood by storm. Elon Musk credited his new body to Wegovy, another brand of the drug, and celebrities like the Kardashians are widely rumoured to be using it to shed the curvy figures that propelled them to fame in the early 2010s.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.